The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis
NCT ID: NCT01258556
Last Updated: 2010-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
150 participants
INTERVENTIONAL
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic yogurt
Yogurt supplemented with L. rhamnosus fiti
200 ml of L. rhamnosus fiti at 10\*9 cfu/ml daily for 30 days.
Placebo yogurt.
Yogurt not supplemented with a probiotic strain.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yogurt supplemented with L. rhamnosus fiti
200 ml of L. rhamnosus fiti at 10\*9 cfu/ml daily for 30 days.
Yogurt not supplemented with a probiotic strain.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being treated with anti-retroviral medication for \> 6 months.
Exclusion Criteria
* Hypersensitive to fermented milk;
* Intolerant for lactose;
* Complaints of bacterial vaginosis requiring treatment
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lawson Health Research Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicodemus Butamanya, MD
Role: PRINCIPAL_INVESTIGATOR
Sekou-Toure Regional Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sekou-Toure Regional Hospital
Mwanza, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
919
Identifier Type: -
Identifier Source: org_study_id